Search research articles
Contact Us
Filters
Showing results (121-130 of 251) with videos related to
Page
of 26
Sort By:
Journal of Medical Virology
|
February 1, 1995
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
E Van Cutsem, R Snoeck, M Van Ranst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2008
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
D Papamichael, R Audisio, J-C Horiot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2005
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial
M Ducreux, E Van Cutsem, J L Van Laethem, et al.
ESMO Open
|
April 5, 2023
A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system
A Coolbrandt, H Tobback, R Govaerts, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 25, 2011
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803
D Sargent, Q Shi, G Yothers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1996
Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group
D Cunningham, J R Zalcberg, U Rath, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 1995
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group
D Cunningham, J R Zalcberg, U Rath, et al.
Gastroenterology
|
January 1, 1992
Effect of motilin on gastric emptying in patients with diabetic gastroparesis
T L Peeters, E Muls, J Janssens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
E Van Cutsem, C Pozzo, H Starkhammar, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 23, 2000
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
P Flamen, A Lerut, E Van Cutsem, et al.
Page
of 26
Search research articles
Search
Showing results (121-130 of 251) with videos related to
Sort By:
Page
of 26
Journal of Medical Virology
|
February 1, 1995
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
E Van Cutsem, R Snoeck, M Van Ranst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2008
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
D Papamichael, R Audisio, J-C Horiot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 5, 2005
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial
M Ducreux, E Van Cutsem, J L Van Laethem, et al.
ESMO Open
|
April 5, 2023
A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system
A Coolbrandt, H Tobback, R Govaerts, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 25, 2011
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803
D Sargent, Q Shi, G Yothers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1996
Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group
D Cunningham, J R Zalcberg, U Rath, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 1995
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group
D Cunningham, J R Zalcberg, U Rath, et al.
Gastroenterology
|
January 1, 1992
Effect of motilin on gastric emptying in patients with diabetic gastroparesis
T L Peeters, E Muls, J Janssens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
E Van Cutsem, C Pozzo, H Starkhammar, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 23, 2000
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
P Flamen, A Lerut, E Van Cutsem, et al.
Page
of 26